Millennium Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,000
Closed -$291K 6253
2024
Q2
$291K Buy
+10,000
New +$297K ﹤0.01% 4931
2023
Q3
Sell
-10,000
Closed -$411K 6309
2023
Q2
$411K Buy
+10,000
New +$481K ﹤0.01% 4670
2023
Q1
Sell
-15,000
Closed -$841K 6577
2022
Q4
$841K Buy
+15,000
New +$763K ﹤0.01% 4333
2022
Q1
Sell
-10,000
Closed -$670K 7143
2021
Q4
$670K Buy
+10,000
New +$677K ﹤0.01% 4780
2021
Q3
Sell
-20,000
Closed -$1.36M 6987
2021
Q2
$1.36M Buy
+20,000
New +$1.41M ﹤0.01% 4367
2021
Q1
Sell
-20,000
Closed -$1.3M 6185
2020
Q4
$1.3M Buy
+20,000
New +$1.08M ﹤0.01% 3560
2020
Q1
Sell
-70,000
Closed -$4.08M 4139
2019
Q4
$4.08M Buy
70,000
+40,000
+133% +$2.38M 0.01% 2094
2019
Q3
$1.8M Buy
30,000
+15,000
+100% +$894K ﹤0.01% 2507
2019
Q2
$838K Sell
15,000
-35,000
-70% -$1.8M ﹤0.01% 2908
2019
Q1
$2.79M Buy
+50,000
New +$2.55M ﹤0.01% 2186
2018
Q4
Sell
-10,000
Closed -$659K 3928
2018
Q3
$659K Buy
+10,000
New +$621K ﹤0.01% 3094
2017
Q4
Sell
-20,000
Closed -$1.01M 3915
2017
Q3
$1.01M Buy
+20,000
New +$1.03M ﹤0.01% 2506

Other funds holding IART

Millennium Management's IART Position: Q1 2026 in Review

Millennium Management increased its Integra LifeSciences (IART) stake by 318% in Q1 2026, buying an estimated $5.2M and bringing the position to 622,853 shares worth $5.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Millennium Management first reported a position in IART in Q3 2013 and has held it in 39 quarters since. The position peaked at $59.3M in Q1 2017. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Millennium Management held 622,853 shares of Integra LifeSciences worth $5.87M as of Q1 2026.
  • Millennium Management bought 473,882 Integra LifeSciences shares in Q1 2026, an estimated $5.2M.
  • Integra LifeSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2765 holding.
  • Millennium Management first reported a position in Integra LifeSciences in Q3 2013 and has held it in 39 quarters since.
  • Millennium Management's Integra LifeSciences position peaked at $59.3M in Q1 2017.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.